Category - New Drugs
FDA Approves Ofev (nintedanib) as First Treatment for Chronic Fibrosing Interstitial Lung Diseases (ILDs) with a Progressive Phenotype
FDA Approves Ofev (Nintedanib), For The Treatment of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype
FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease
FDA Approves Durysta (bimatoprost implant) to Lower Intraocular Pressure In Open-Angle Glaucoma or Ocular Hypertension Patients
FDA Approves Pizensy (lactitol) for the Treatment of Chronic Idiopathic Constipation in Adults
FDA Approves Sarclisa (isatuximab-irfc) for Patients with Relapsed Refractory Multiple Myeloma
FDA Approves Advil Dual Action (ibuprofen and acetaminophen) as an Over-the-Counter Pain Treatment
FDA Approves Nurtec ODT (rimegepant) for the Acute Treatment of Migraine in Adults